Co-Diagnostics, Inc. (CODX) vs Enveric Biosciences, Inc. (ENVB)

A side-by-side comparison of Co-Diagnostics, Inc. and Enveric Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Co-Diagnostics, Inc. logo
CODX
Co-Diagnostics, Inc.
$7M
$1.10HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Enveric Biosciences, Inc. logo
ENVB
Enveric Biosciences, Inc.
$7M
$1.51HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — CODX vs ENVB

growth of $100 · dividends reinvested · last 9y
CODX -98.9% (-39.4%/yr)ENVB -100.0% (-78.8%/yr)CODX compounded faster over this window
Log scale — wide-divergence pair
000001101001kStart $1002019202120232025$1$0
CODX ENVB

CODX vs ENVB: by the numbers

  • •CODX is the larger company ($7M vs $7M market cap).
  • •Both run net losses; ENVB's is the smaller (0.00% vs -6523.04% net margin).

Metrics side by side

Valuation

MetricCODXENVB
P/S ratio9.53N/A
P/B ratio0.540.84

Profitability

MetricCODXENVB
Gross margin64.28%0.00%
Operating margin-5025.53%0.00%
Net margin-6523.04%0.00%
ROE-370.16%-108.00%
ROIC-219.15%-107.99%

Growth (annualized)

MetricCODXENVB
Revenue CAGR (5Y)-62.43%N/A
Total return CAGR (5Y)-66.53%N/A

Go deeper

Full CODX analysisFull ENVB analysisInteractive comparison tool

Dig into the metrics

Co-Diagnostics ROEEnveric Biosciences ROECo-Diagnostics operating marginEnveric Biosciences operating marginCo-Diagnostics revenue growthEnveric Biosciences revenue growthCo-Diagnostics free cash flowEnveric Biosciences free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.